NCT03571594View on ClinicalTrials.gov

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

May 16, 2019

Study Completion Date

May 16, 2019

Conditions
Acromegaly
Interventions
DRUG

ONO-5788

Investigational drug

DRUG

ONO-5788 Placebo

Placebo Comparator

DRUG

Octreotide

Active Comparator in Part D

Trial Locations (1)

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY